盘状红斑狼疮

参考文献

关键文献

Patel P, Werth V. Cutaneous lupus erythematosus: a review. Dermatol Clin. 2002;20:378-385. 摘要

参考文献

1. Provost TT. The relationship between discoid and systemic lupus erythematosus. Arch Dermatol. 1994;130:1308-1310. 摘要

2. Healy E, Kieran E, Rogers S. Cutaneous lupus erythematosus - a study of clinical and laboratory prognostic factors in 65 patients. Ir J Med Sci. 1995;164:113-115. 摘要

3. Pistiner M, Wallace DJ, Nessim S, et al. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin Arthritis Rheum. 1991;21:55-64. 摘要

4. Tebbe B. Clinical course and prognosis of cutaneous lupus erythematosus. Clin Dermatol. 2004;22:121-124. 摘要

5. Siegel M, Lee SL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum. 1973;3(1):1-54. 摘要

6. Santiago-Casas Y, Vilá LM, McGwin G Jr, et al. Association of discoid lupus with clinical manifestations and damage accrual in a multiethnic lupus cohort. Arthritis Care Res (Hoboken). 2012;64:704-712.全文  摘要

7. Gallego H, Crutchfield CE 3rd, Lewis EJ, et al. Report of an association between discoid lupus erythematosus and smoking. Cutis. 1999;63:231-234. 摘要

8. Miot HA, Bartoli Miot LD, Haddad GR. Association between discoid lupus erythematosus and cigarette smoking. Dermatology. 2005;211:118-122. 摘要

9. Knop J, Bonsmann G, Kind P, et al. Antigens of the major histocompatibility complex in patients with chronic discoid lupus erythematosus. Br J Dermatol. 1990;122:723-728. 摘要

10. Seitz CS, Brocker EB, Trautmann A. Linear variant of chronic cutaneous lupus erythematosus: a clue for the pathogenesis of chronic cutaneous lupus erythematosus? Lupus. 2008;17:1136-1139. 摘要

11. Lin JH, Dutz JP, Sontheimer RD, et al. Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol. 2007;33:85-106. 摘要

12. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271-7. 摘要

13. Patel P, Werth V. Cutaneous lupus erythematosus: a review. Dermatol Clin. 2002;20:378-385. 摘要

14. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 Sep;40(9):1725.全文  摘要

15. Jessop S, Whitelaw DA, Grainge MJ, et al. Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev. 2017;(5):CD002954.全文  摘要

16. Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. 2006;24:348-362. 摘要

17. Callen JP. Management of "refractory" skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol. 2005;19:767-784. 摘要

18. Wenzel J, Brähler S, Bauer R, et al. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Br J Dermatol. 2005;153:157-162. 摘要

19. Callen JP, Spencer LV, Burruss JB, et al. Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol. 1991;127:515-522. 摘要

20. Goyal S, Nousari HC. Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol. 2001;45:142-144. 摘要

21. Stevens RJ, Andujar C, Edwards CJ, et al. Thalidomide in the treatment of the cutaneous manifestations of lupus erythematosus: experience in sixteen consecutive patients. Br J Rheumatol. 1997;36:353-359.全文  摘要

22. Pelle MT, Werth VP. Thalidomide in cutaneous lupus erythematosus. Am J Clin Dermatol. 2003;4:379-387. 摘要

23. Cuadrado MJ, Karim Y, Sanna G, et al. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens. Am J Med. 2005;118:246-250. 摘要

24. Sugano M, Shintani Y, Kobayashi K, et al. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus. J Dermatol. 2006;33:887-891. 摘要

25. Lampropoulos C, Sangle S, Harrison P, et al. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative. Rheumatology (Oxford). 2004;43:1383-1385.全文  摘要

26. Tlacuilo-Parra A, Guevara-Gutierrez E, Gutierrez-Murillo F, et al. Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus. Rheumatology (Oxford). 2005;44:1564-1568.全文  摘要

27. Tzellos TG, Kouvelas D. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation. Eur J Clin Pharmacol. 2008;64:337-341. 摘要

28. Rahman P, Gladman DD, Urowitz MB. Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol. 1998;25:1716-1719. 摘要

29. Baniandres O, Boixeda P, Belmar P, et al. Treatment of lupus erythematosus with pulsed dye laser. Lasers Surg Med. 2003;32:327-330. 摘要

30. Erceq A, Bovenschen HJ, van de Kerkhof PC, et al. Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus. J Am Acad Dermatol. 2009;60:626-632. 摘要

31. Eskreis BD, Eng AM, Furey NL. Surgical excision of trauma-induced verrucous lupus erythematosus. J Dermatol Surg Oncol. 1988;14:1296-1299. 摘要

32. Sulica VI, Kao GF. Squamous-cell carcinoma of the scalp arising in lesions of discoid lupus erythematosus. Am J Dermatopathol. 1988;10:137-141. 摘要

内容使用需遵循免责声明